Contineum Therapeutics (CTNM) Revenue (2023)
Contineum Therapeutics' (CTNM) quarterly Revenue came in at $50.0 million in Q2 2023.
Contineum Therapeutics (CTNM) Revenue (2023) Analysis & Trends
Contineum Therapeutics' Revenue history runs 1 years deep, the most recent figure standing at $50.0 million for Q2 2023.
- On a quarterly basis, Revenue changed N/A year-over-year to $50.0 million in Q2 2023; TTM through Jun 2024 was $50.0 million, a N/A change from a year earlier, with the FY2023 full-year figure at $50.0 million, changed N/A from the prior year.
- Revenue steadied at $50.0 million in Q2 2023 per CTNM's latest filing.
- Across five years, Revenue topped out at $50.0 million in Q2 2023 and bottomed at $50.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 50.00 Mn |